#hemolysis

• Achromatocyte — A pathologically degraded erythrocyte that has completely lost its hemoglobin content, appearing under the microscope as a pale, discolored, or empty cellular structure; a residual red blood cell (erythrocyte ghost) resulting from a severe hemolytic process or mechanical membrane trauma.
• Achromatocyte — A pathological erythrocyte cell form or degraded stage of a red blood cell that has partially or completely lost its normal hemoglobin content, appearing under the microscope as a pale, semitransparent, or fully pigment-depleted cellular structure. This structural phenomenon typically occurs following severe intravascular hemolysis, mechanical cell membrane trauma, or intense osmotic alterations, leaving behind a residual membrane known in specialized literature as an erythrocyte ghost.
• Antihemolytic — Preventing, combating, or stopping hemolysis (the parasitic or pathological process of red blood cell destruction and subsequent release of hemoglobin into the plasma); a chemical substance, antibody, or biological factor that protects the structural integrity of the erythrocyte membrane. In a clinical sense, it is utilized in the treatment of hemolytic anemias to stabilize blood cells.
• Autohemolysis — A pathological biological process consisting of the spontaneous and premature destruction of red blood cells (erythrocytes) within the blood due to the action of the organism's own serum or autoantibodies; a clinical laboratory test used to diagnose congenital or acquired hemolytic anemias.